Clinical Trials Logo

Clinical Trial Summary

Tuberculosis (TB) is a major cause of death among the "communicable" diseases in the world. Pulmonary TB, the main localization, leads to the dissemination of cases. An earlier diagnosis of contagious pulmonary TB is a cornerstone to stop the air transmission. The aim of the study will be to compare two strategies, in patients with a chest-X-ray in favour of contagious pulmonary TB: the classical strategy of sputa collection during three consecutive early mornings, versus the studied strategy of sputa collection at hour h, hour h+1, hour h+2 during the first early morning.


Clinical Trial Description

Tuberculosis (TB) is a major cause of death among the "communicable" diseases in the world. Pulmonary TB, the main localization, leads to the dissemination of cases. An earlier diagnosis of contagious pulmonary TB is a cornerstone to stop the air transmission by starting earlier treatment. The aim of the study will be to compare two strategies, in patients with a chest-X-ray in favour of pulmonary TB: the classical strategy of sputa collection during three consecutive early mornings, versus the studied strategy of sputa collection at hour h, hour h+1, hour h+2 during the first early morning. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02961569
Study type Interventional
Source Hopital Lariboisière
Contact
Status Completed
Phase N/A
Start date July 2016
Completion date April 2017

See also
  Status Clinical Trial Phase
Completed NCT00933790 - Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis Phase 3
Completed NCT04645836 - Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'. N/A
Recruiting NCT06058299 - Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis Phase 2
Completed NCT03722472 - Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults Phase 1
Completed NCT03678688 - A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis Phase 1/Phase 2
Completed NCT00212550 - Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb N/A
Recruiting NCT03025516 - Performance Evaluation of TB Breath- and Cough-testing Platforms N/A
Recruiting NCT05426720 - Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
Recruiting NCT04264221 - Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging N/A
Active, not recruiting NCT05221502 - Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB Phase 2